Works matching IS 15228517 AND DT 2022 AND VI 24 AND IP 2
Results: 21
Targeting nicotinamide adenosine dinucleotide (NAD) in diffuse gliomas.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 245, doi. 10.1093/neuonc/noab265
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 329, doi. 10.1093/neuonc/noac002
- Publication type:
- Article
External controls to improve on glioblastoma clinical trials.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 257, doi. 10.1093/neuonc/noab251
- By:
- Publication type:
- Article
Faraway, so close: Intratumoral heterogeneity of medulloblastoma subgroups.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
How mutant isocitrate dehydrogenase orchestrates immune cells.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 210, doi. 10.1093/neuonc/noab266
- By:
- Publication type:
- Article
Long telomeres in need of a SNP: Germline contributions of telomere maintenance to glioma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 182, doi. 10.1093/neuonc/noab260
- By:
- Publication type:
- Article
Patients with primary brain tumors and COVID-19: A report from the Dutch Oncology COVID-19 Consortium.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 326, doi. 10.1093/neuonc/noab258
- By:
- Publication type:
- Article
Low and steady wins the race: For melanoma brain metastases, is prevention better than a cure?
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 226, doi. 10.1093/neuonc/noab267
- By:
- Publication type:
- Article
Age at diagnosis and sex interact to modify primary malignant glioma incidence and survival.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
data behind the image—Deep learning and its potential impact in neuro-oncological imaging.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 300, doi. 10.1093/neuonc/noab249
- By:
- Publication type:
- Article
Extracellular vesicles: The key for precision medicine in glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 184, doi. 10.1093/neuonc/noab229
- By:
- Publication type:
- Article
Relationship between genetically determined telomere length and glioma risk.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 171, doi. 10.1093/neuonc/noab208
- By:
- Publication type:
- Article
Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 302, doi. 10.1093/neuonc/noab199
- By:
- Publication type:
- Article
Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 259, doi. 10.1093/neuonc/noab182
- By:
- Publication type:
- Article
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 229, doi. 10.1093/neuonc/noab175
- By:
- Publication type:
- Article
EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlations.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 313, doi. 10.1093/neuonc/noab174
- By:
- Publication type:
- Article
PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 213, doi. 10.1093/neuonc/noab159
- By:
- Publication type:
- Article
Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesicles.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 197, doi. 10.1093/neuonc/noab153
- By:
- Publication type:
- Article
Deep learning-based automatic tumor burden assessment of pediatric high-grade gliomas, medulloblastomas, and other leptomeningeal seeding tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 289, doi. 10.1093/neuonc/noab151
- By:
- Publication type:
- Article
use of external control data for predictions and futility interim analyses in clinical trials.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 247, doi. 10.1093/neuonc/noab141
- By:
- Publication type:
- Article
Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 273, doi. 10.1093/neuonc/noab135
- By:
- Publication type:
- Article